93 related articles for article (PubMed ID: 8755859)
1. [Interleukin 6 (IL-6)--clinical significance].
Kamińska B; Gradowska L; Paczek L
Pol Arch Med Wewn; 1996 Mar; 95(3):270-6. PubMed ID: 8755859
[No Abstract] [Full Text] [Related]
2. IL6 and lymphoproliferative disorders.
Brouet JC; Levy Y
Nouv Rev Fr Hematol (1978); 1991; 33(6):433-6. PubMed ID: 1818294
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 in autoimmune disorders.
Yoshizaki K; Kuritani T; Kishimoto T
Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
[TBL] [Abstract][Full Text] [Related]
4. Technology evaluation: MRA, Chugai.
Ding C; Jones G
Curr Opin Mol Ther; 2003 Feb; 5(1):64-9. PubMed ID: 12669473
[TBL] [Abstract][Full Text] [Related]
5. [The importance of interleukin 6 (IL-6) in pathogenesis and diagnosis of renal glomerular diseases].
Kacprzyk F
Postepy Hig Med Dosw; 1995; 49(4):513-22. PubMed ID: 8657645
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of interleukin-6 assay].
Horii Y; Hirano T
Nihon Rinsho; 1990 Feb; 48 Suppl():818-21. PubMed ID: 2162432
[No Abstract] [Full Text] [Related]
7. [Rheumatoid arthritis as a risk factor for development of multiple myeloma].
Usnarska-Zubkiewicz L; Czarnecka M; Włodarczyk S; Nowak E
Pol Arch Med Wewn; 1997 Mar; 97(3):253-9. PubMed ID: 9333771
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-6 for the treatment of inflammatory diseases.
Nishimoto N; Kishimoto T
Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6: structure-function relationships.
Simpson RJ; Hammacher A; Smith DK; Matthews JM; Ward LD
Protein Sci; 1997 May; 6(5):929-55. PubMed ID: 9144766
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6: from bench to bedside.
Nishimoto N; Kishimoto T
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of cytokines.
Fridman WH; Michon J
Leuk Res; 1990; 14(8):675-7. PubMed ID: 2201818
[TBL] [Abstract][Full Text] [Related]
12. [Interleukin 6 and disease].
Kaisho T; Hirano T
Ryumachi; 1991 Jun; 31(3):318-26. PubMed ID: 1948452
[No Abstract] [Full Text] [Related]
13. [New therapeutic strategy for autoimmune diseases. 3) Treatment of autoimmune diseases by cytokine signal transduction inhibition].
Nishimoto N; Yoshizaki K; Kishimoto T
Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1745-50. PubMed ID: 9816842
[No Abstract] [Full Text] [Related]
14. [Oligosaccharide structures of IgG in multiple myeloma and Castleman's disease].
Nishiura T; Nakao H; Kanayama Y; Nishikawa A; Taniguchi N
Tanpakushitsu Kakusan Koso; 1992 Aug; 37(11 Suppl):1945-50. PubMed ID: 1410487
[No Abstract] [Full Text] [Related]
15. The "new" interleukins.
Romagnani S
Allergol Immunopathol (Madr); 1991; 19(3):136-42. PubMed ID: 1799172
[No Abstract] [Full Text] [Related]
16. [Anti-IL-6 receptor antibody].
Nishimoto N
Nihon Rinsho; 2005 May; 63 Suppl 5():723-7. PubMed ID: 15954436
[No Abstract] [Full Text] [Related]
17. A woman with rheumatoid arthritis, Sjögren's syndrome, leg ulcer, and significant weight loss.
Kerr GS; Aggarwal A; McDonald-Pinkett S
Arthritis Care Res (Hoboken); 2012 May; 64(5):785-92. PubMed ID: 22290720
[No Abstract] [Full Text] [Related]
18. Membranoproliferative glomerulonephritis in the setting of multicentric angiofollicular lymph node hyperplasia (Castleman's disease) complicated by Evan's syndrome.
Gakiopoulou H; Korkolopoulou P; Paraskevakou H; Marinaki S; Voulgarelis M; Stofas A; Lelouda M; Lazaris AC; Boletis J; Patsouris E
J Clin Pathol; 2010 Jun; 63(6):552-4. PubMed ID: 20439324
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-6 in multiple myeloma.
Bataille R; Klein B
Ann Med Interne (Paris); 1992; 143 Suppl 1():77-9. PubMed ID: 1300892
[No Abstract] [Full Text] [Related]
20. Interleukin-6: discovery of a pleiotropic cytokine.
Kishimoto T
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S2. PubMed ID: 16899106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
